#303: The AI Stocks No One is Talking About: Biotech Boom

#303: The AI Stocks No One is Talking About: Biotech Boom

Author: MyWallSt March 19, 2026 Duration: 47:38

This week, Emmet and Mike are digging into one of the hottest trends of our futuristic world: human longevity. We’ve all seen Bryan Johnson on our social feeds, but the business of living longer is more than just a meme. Today, new-age pharmaceutical companies are leveraging AI to reinvent the drug development process—making it faster, cheaper, and more customizable. If they’re successful, it could become one of the most important scientific innovations of all time.

This raises the question: how do you invest in it?

Emmet sees four categories:

  • Metabolic longevity — Eli Lilly, Novo Nordisk
  • Early disease detection — Guardant Health, Exact Sciences
  • Longevity infrastructure — Thermo Fisher, Danaher Corp
  • Moonshots — Recursion Pharmaceuticals Inc

But which stocks are the lads’ favorites?

Mike favors Tempus AI (TEM) for its two-pronged business model, composed of diagnostics and data. The diagnostics side is similar to Guardant Health, focusing on hereditary and sequencing tests. The data side consists of vast libraries of medical data that are licensed to other pharma and biotech companies, enabling things like trial design, pre-validation, and patient enrollment. They also have some impressive stats: net revenue retention sits at 126%, and they have over a billion dollars in backlog.

Emmet goes with a stock he previously added to his watchlist, but later removed due to its complexity: Recursion Pharmaceuticals. It has a validated, full-stack platform for AI-driven drug discovery, but currently licenses data from Tempus AI. It recently achieved its first patented result from its AI system, which is considered a major breakthrough.

They wrap up by sharing which stock they would invest in today.


In celebration of St. Patrick’s Day, all of our services are on sale. From Horizon to Prophet, it’s a great time to find your next life-changing investment (at a discount). Importantly, our Insider Bot lives inside Horizon so if you want to invest like a CEO or CFO now is the time.

To lock in your special rate, email frank@mywallst.com

Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/

Become a successful investor by checking out all the content MyWallSt has to offer:

📩 Email us: pod@mywallst.com

📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7

💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/

🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/

🎉 Follow MyWallSt on social:

❌ X: @MyWallStHQ

💃 TikTok: @MyWallSt

📸 Instagram: @MyWallSt

🖥️ Facebook: @MyWallSt

👔 LinkedIn: MyWallSt

00:00 Intro01:31 Why Longevity Matters07:31 Demis Hassabis on the Future of AI15:08 Longevity Investing Archetypes24:16 Tempus AI Overview31:39 Recursion Pharma Pitch45:07 10K Portfolio Split



Each week on Stock Club, the team from MyWallSt gathers to break down the movements and ideas shaping the market. This isn't about hype or frantic trading tips; it's a grounded conversation focused on understanding how investing actually works. You'll hear them analyze specific stock news and discuss the strategies behind building lasting wealth, all with the aim of making you a more thoughtful and confident investor. The discussion in this podcast naturally evolves from the week's most significant events, offering clarity on complex financial stories without relying on jargon. Tuning in feels like being part of a straightforward, informed discussion where the priority is long-term perspective over short-term noise. For anyone looking to deepen their grasp of the business and investing landscape, Stock Club provides a consistent, reliable space to learn. It’s the regular check-in that helps demystify the market's shifts, emphasizing education and insight as the true foundations for success. You can find Stock Club wherever you listen to podcasts.
Author: Language: English Episodes: 50

Stock Club
Podcast Episodes
#288: An International Multibagger Stock to Buy Right Now [not-audio_url] [/not-audio_url]

Duration: 57:01
After the recent launch of Nexus III and last week’s peek behind the curtain of Nexus I and II, we’re bringing you one more Nexus sample.Fresh from Nexus’ latest crop of stocks, Mike pitches a business essential to the A…
#287: 2 Stock with 10X Potential From Across the Globe [not-audio_url] [/not-audio_url]

Duration: 49:23
Mike and Emmet head back to foreign shores to talk about their favorite stocks from Nexus I and II in honor of the launch of Nexus III.Nexus, MyWallSt’s international portfolio, aims to ensure every long-term, high-growt…
#286: The S&P 500’s Most Undervalued Stock? [not-audio_url] [/not-audio_url]

Duration: 48:17
As SoftBank sells off its Nvidia holdings to free up capital for OpenAI, it might be time to look for something with a less eye-watering valuation.Adobe, once one of Wall Street’s most beloved SaaS players, is down nearl…
#285: What Stocks to Buy in a Market Crash? (w/ Sean Tepper) [not-audio_url] [/not-audio_url]

Duration: 38:20
This week, Mike is joined by Sean Tepper, the founder of Tykr, a platform focused on turning Wall Street newbies into confident investors.Like Mike and Emmet, Sean believes the stock market is a powerful tool for regular…
#284: The Warren Buffett Stock No One Is Talking About [not-audio_url] [/not-audio_url]

Duration: 48:56
In a surprise double feature, Mike and Emmet bring you two more “boring,” Peter Lynch–style businesses to ground your portfolio. In the wake of AI-fueled Big Tech layoffs, the market is undeniably frothy — so it’s a grea…
#283: 2 Cheap Value Stocks to Buy Right Now [not-audio_url] [/not-audio_url]

Duration: 57:35
Stock Club is usually home to high-risk, high-reward tech stocks on the cutting edge of tomorrow, but this week, Emmet and Mike bring you two down-to-earth value stocks that hold a special place in their hearts. While th…
#282: Is Intel a Turnaround Play? — INTC Stock Analysis [not-audio_url] [/not-audio_url]

Duration: 51:48
Emmet and Mike are back to discuss the latest stock market moves.Mike breaks down the U.S. government’s attempts to reduce reliance on foreign companies by investing in homegrown alternatives. The rare metals market is d…
#280: A Healthcare Stock on Emmet’s Watchlist [not-audio_url] [/not-audio_url]

Duration: 51:23
This week, Mike and Emmet venture onto the shores of the healthcare industry to identify some potential hundred-baggers.Emmet breaks down Oscar Health, a stock often discussed by investors on X and Reddit. The company wa…